losartan has been researched along with n(6)-cyclopentyladenosine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrett, RJ; Droppleman, DA | 1 |
Chen, H; McClure, JM; O'Leary, DS; Rossi, NF; Scislo, TJ | 1 |
2 other study(ies) available for losartan and n(6)-cyclopentyladenosine
Article | Year |
---|---|
Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
Topics: Adenine; Adenosine; Angiotensin II; Animals; Arginine; Arginine Vasopressin; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Imidazoles; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Purinergic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Regional Blood Flow; Renal Circulation; Serotonin; Tetrazoles; Thromboxane A2; Vascular Resistance; Vasoconstriction | 1993 |
Vasopressin is a major vasoconstrictor involved in hindlimb vascular responses to stimulation of adenosine A(1) receptors in the nucleus of the solitary tract.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adrenalectomy; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Baroreflex; Blood Pressure; Heart Rate; Hindlimb; Iliac Artery; Losartan; Male; Microinjections; Muscle, Skeletal; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptor, Angiotensin, Type 1; Receptors, Vasopressin; Regional Blood Flow; Solitary Nucleus; Sympathectomy; Time Factors; Vasoconstriction; Vasopressins | 2009 |